XML 27 R18.htm IDEA: XBRL DOCUMENT
v3.23.3

REVENUE CONCENTRATION | 9 Months Ended
--- | ---
Jun. 30, 2023
Risks and Uncertainties [Abstract] |
REVENUE CONCENTRATION | 12. REVENUE CONCENTRATION For the three months ended June 30, 2023, the Company derived revenue of $7.0 million from one customer, with such customer accounting for 16% of the Company’s total revenue. For the three months ended June 30, 2022, the Company derived revenue of $13.6 million from three customers, with such customers accounting for 14%, 10%, and 10% of the Company’s total revenue, respectively. For the nine months ended June 30, 2023, the Company derived revenue of $35.2 million from two customers, with such customers accounting for 15% and 11% of the Company’s total revenue, respectively. For the nine months ended June 30, 2022, the Company derived revenue of $16.9 million from one customer, with such customer accounting for 16% of the Company’s total revenue. The corresponding accounts receivable balances of customers from which revenues were in excess of 10% of total revenue were $7.1 million and $5.3 million at June 30, 2023 and 2022, respectively. International sales accounted for approximately 29% and 28% of the Company’s total revenue in the three months ended June 30, 2023 and 2022, respectively. For the nine months ended June 30, 2023 and 2022, international sales accounted for approximately 25% and 29% of the Company’s total revenue, respectively. From a geographic perspective, approximately 70% and 69% of the Company’s total long-term assets as of June 30, 2023 and September 30, 2022, respectively, are associated with the Company’s international subsidiaries. From a geographic perspective, approximately 16% and 19% of the Company’s total long-term assets excluding goodwill and other intangible assets as of June 30, 2023 and September 30, 2022, respectively, are associated with the Company’s international subsidiaries.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration